Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Arie C. Van Loenen"'
Publikováno v:
Annals of Pharmacotherapy, 42, 1605-12
Annals of Pharmacotherapy, 42, 11, pp. 1605-12
Annals of Pharmacotherapy, 42, 11, pp. 1605-12
Background: When choosing the active control group in a randomized that, it is important to maintain standard treatment for the therapeutic indication for which a medicine is studied. This choice is relevant not only for demonstrating the efficacy an
Autor:
Eleonora L. Swart, Catharina M. van Rij, Adriaan A. Lammertsma, Eric J.F. Franssen, Arie C. van Loenen, Alwin D. R. Huitema, H. N. Greuter
Publikováno v:
British Journal of Clinical Pharmacology. 60:477-485
Objective The objectives of the study were to develop a population pharmacokinetic model for 11C-flumazenil at tracer concentrations, to assess the effects of patient-related covariates and to derive an optimal sampling protocol for clinical use. Met
Autor:
Arie C. van Loenen, Andrea Wittig, Catharina M. van Rij, Arno Sinjewel, Wolfgang Sauerwein, Otomar Kriz, Abraham J. Wilhelm
Publikováno v:
American Journal of Health-System Pharmacy. 62:2608-2610
Boron neutron capture therapy (BNCT) is a promising technique for highly targeted tumor therapy.[1][1],[2][2] BNCT relies on the high cross-section of the nonradioactive isotope boron-10 to capture thermal neutrons, leading to the reaction 10B(n,α)7
Autor:
Emiel M. Spoelder, Eke N. Bakker, Arie C. Van Loenen, M. F. M. Wagemans, Wouter W.A. Zuurmond, Jaap J. de Lange
Publikováno v:
Pain. 61:55-59
Terminally ill patients suffering from intractable cancer pain are treated in our hospital on an outpatient basis with a percutaneous intrathecal (i.t.) catheter and a portable pump delivering morphine continuously. In a patient showing an increased
Publikováno v:
Pharmacy worldscience : PWS. 27(2)
Aim: Glioblastoma multiforme (GBM) is an incurable disease that can only be managed in a palliative way. The GBM accounts for approximately half of all newly diagnosed primary brain tumors with an incidence of 2–3 cases per 100,000 people each year
Publikováno v:
Pharmacy World & Science; Apr2005, Vol. 27 Issue 2, p92-95, 4p
Publikováno v:
Pharmaceutisch Weekblad. 10:281-283
A pharmacokinetic analysis of cefoxitin in women undergoing caesarean section under general anaesthesia, was performed. In order to prevent infections postoperatively three doses of cefoxitin--2, 1 and 1 g, respectively--were given as a 3-min intrave